Jon Congleton, Mineralys CEO
RA Capital backs a Philly biotech's $118M crossover as it aims to break into the hypertension space
While the hypertension market becomes ever more crowded with candidates as J&J tosses its hat into the ring, a Pennsylvania-based startup is looking to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
